FDA scientists say evidence is insufficient to support compounding seven popular peptide therapies backed by Health Secretary Robert F. Kennedy Jr. An advisory panel with some peptide-industry ties will review the products in July.
Posts tagged as “several Food and Drug Administration”
Key takeaways: The Supreme Court has agreed to weigh appeals from the Biden administration and drugmaker Danco defending several FDA decisions that made it easier…